-
公开(公告)号：US20110207931A1
公开(公告)日：2011-08-25
申请号：US13031691
申请日：2011-02-22
申请人： Srinivas Katkam , Rajeswar Reddy Sagyam , Madhusudhan Reddy Ganta , Babu Ireni , Srihari Babu Korrothu , Raghavendar Rao Morthala , Narsimha Rao Pagadala , Veera Venkata Satyanarayana Murthy Kondepudi
发明人： Srinivas Katkam , Rajeswar Reddy Sagyam , Madhusudhan Reddy Ganta , Babu Ireni , Srihari Babu Korrothu , Raghavendar Rao Morthala , Narsimha Rao Pagadala , Veera Venkata Satyanarayana Murthy Kondepudi
IPC分类号： C07D473/18
CPC分类号： C07D473/18
摘要： The application relates to processes for preparing valganciclovir and pharmaceutically acceptable salts thereof, as well as intermediates for the processes. valganciclovir hydrochloride is represented by Formula II.
摘要翻译： 本申请涉及制备缬更昔洛韦及其药学上可接受的盐的方法，以及该方法的中间体。 盐酸缬更昔洛韦由式II表示。
-
公开(公告)号：US20140235895A1
公开(公告)日：2014-08-21
申请号：US14114305
申请日：2012-04-27
申请人： Srinivas Katkam , Rajeswar Reddy Sagyam , Raghavendar Rao Morthala , Babu Ireni , Krishna Vinigari , Suresh Kumar Ramdoss , Srinivasulu Rangineni , Arjunkumar Tummala , Javed Iqbal , Srinivas Oruganti , Bhaskar Kandagatla
发明人： Srinivas Katkam , Rajeswar Reddy Sagyam , Raghavendar Rao Morthala , Babu Ireni , Krishna Vinigari , Suresh Kumar Ramdoss , Srinivasulu Rangineni , Arjunkumar Tummala , Javed Iqbal , Srinivas Oruganti , Bhaskar Kandagatla
IPC分类号： C07C205/45 , C07C213/10 , C07C215/28 , C07C213/00
CPC分类号： C07C205/45 , C07C201/10 , C07C201/12 , C07C213/00 , C07C213/02 , C07C213/10 , C07C215/28 , C07C205/04
摘要： The present application provide processes for the preparation of fingolimod and its pharmaceutically acceptable salts, process for the purification of fingolimod hydrochloride and process for the preparation of amorphous fingolimod hydrochloride.
摘要翻译： 本申请提供了芬戈莫德及其药学上可接受的盐的制备方法，盐酸芬戈莫德的纯化方法和用于制备无定形芬戈莫德盐酸盐的方法。
-
公开(公告)号：US09216943B2
公开(公告)日：2015-12-22
申请号：US14114305
申请日：2012-04-27
申请人： Srinivas Katkam , Rajeswar Reddy Sagyam , Raghavendar Rao Morthala , Babu Ireni , Krishna Vinigari , Suresh Kumar Ramdoss , Srinivasulu Rangineni , Arjunkumar Tummala , Javed Iqbal , Srinivas Oruganti , Bhaskar Kandagatla
发明人： Srinivas Katkam , Rajeswar Reddy Sagyam , Raghavendar Rao Morthala , Babu Ireni , Krishna Vinigari , Suresh Kumar Ramdoss , Srinivasulu Rangineni , Arjunkumar Tummala , Javed Iqbal , Srinivas Oruganti , Bhaskar Kandagatla
IPC分类号： C07C205/45 , C07C201/10 , C07C201/12 , C07C213/02 , C07C215/28 , C07C213/00 , C07C213/10
CPC分类号： C07C205/45 , C07C201/10 , C07C201/12 , C07C213/00 , C07C213/02 , C07C213/10 , C07C215/28 , C07C205/04
摘要： The present application provide processes for the preparation of fingolimod and its pharmaceutically acceptable salts, process for the purification of fingolimod hydrochloride and process for the preparation of amorphous fingolimod hydrochloride.
摘要翻译： 本申请提供了芬戈莫德及其药学上可接受的盐的制备方法，盐酸芬戈莫德的纯化方法和用于制备无定形芬戈莫德盐酸盐的方法。
-
公开(公告)号：US07074818B2
公开(公告)日：2006-07-11
申请号：US10483580
申请日：2002-01-07
申请人： Satyanarayana Reddy Manne , Nagaraju Chakilam , Srinivasulu Gudipati , Srinivas Katkam , Rajeswar Reddy Sagyam
发明人： Satyanarayana Reddy Manne , Nagaraju Chakilam , Srinivasulu Gudipati , Srinivas Katkam , Rajeswar Reddy Sagyam
IPC分类号： A61K31/40 , C07D207/00
CPC分类号： C07D207/34
摘要： The present invention relates to novel crystalline forms of atorvastatin calcium and to the methods of their production and isolation. More specifically, the present invention relates to novel Forms VI and VII of R—(R*,R*)]-2(4-fluorophenyl)-B,d dihydroxy-5(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-H-pyrrole-1-heptanoic- acid calcium salt and hydrates thereof and to methods of their preparation.
摘要翻译： 本发明涉及阿托伐他汀钙的新型结晶形式及其生产和分离方法。 更具体地说，本发明涉及R-（R *，R *）] - 2（4-氟苯基）-B，d-二羟基-5（1-甲基乙基）-3-苯基-4- [（苯基氨基）羰基] -1-H-吡咯-1-庚酸钙盐及其水合物及其制备方法。
-
公开(公告)号：US08779161B2
公开(公告)日：2014-07-15
申请号：US13703555
申请日：2011-06-16
申请人： Srinivas Katkam , Srinivas Polavarapu , Venkata Madhavi Yaddanapudi , Krishna Vinigari , Narasimha Rao Pagadala , Rajeshwar Reddy Sagyam
发明人： Srinivas Katkam , Srinivas Polavarapu , Venkata Madhavi Yaddanapudi , Krishna Vinigari , Narasimha Rao Pagadala , Rajeshwar Reddy Sagyam
IPC分类号： C07D491/044
CPC分类号： C07D491/04 , C07D491/044
摘要： Aspects of the present application relate to a microcrystalline monoclinic form of asenapine maleate represented by structural Formula (I); processes for its preparation; and pharmaceutically acceptable dosage forms thereof.
摘要翻译： 本申请的方面涉及由结构式（I）表示的微晶单斜晶形式的马来酸asenapine; 其准备过程; 及其药学上可接受的剂型。
-
6.发明申请PREPARATION OF ATORVASTATIN CALCIUM FORM VI AND COMPOSITIONS THEREOF 审中-公开ATORVASTATIN钙形式VI及其组合物的制备公开(公告)号：US20080051449A1
公开(公告)日：2008-02-28
申请号：US11668608
申请日：2007-01-30
申请人： Sudeep Agrawal , Pratibha Bhat , Srinivasulu Gudipati , Srinivas Katkam , Satyanarayana Komati , Indu Bhushan , Mailatur Mohan
发明人： Sudeep Agrawal , Pratibha Bhat , Srinivasulu Gudipati , Srinivas Katkam , Satyanarayana Komati , Indu Bhushan , Mailatur Mohan
IPC分类号： A61K31/40 , A61P9/00 , C07D207/30
CPC分类号： C07D207/34
摘要： The present invention provides processes to prepare atorvastatin calcium Form VI, pharmaceutical compositions comprising atorvastatin calcium Form VI, and processes to prepare said compositions. An aspect of the invention relates to atorvastatin calcium Form VI compositions having enhanced bioavailability when administered orally to humans.
摘要翻译： 本发明提供了制备阿托伐他汀钙形式VI的方法，包含阿托伐他汀钙型VI的药物组合物和制备所述组合物的方法。 本发明的一个方面涉及当向人类口服施用时具有增强的生物利用度的阿托伐他汀钙VI型组合物。
-
公开(公告)号：US20070032665A1
公开(公告)日：2007-02-08
申请号：US11462084
申请日：2006-08-03
IPC分类号： C07D207/24
CPC分类号： C07D207/34
摘要： A process for preparing atorvastatin calcium Form I, comprising adding a solution comprising atorvastatin calcium and an alcohol to water. Optionally, the water can contain seed crystals of atorvastatin calcium Form I.
摘要翻译： 制备阿托伐他汀钙I型的方法，包括将包含阿托伐他汀钙和醇的溶液加入到水中。 任选地，水可以含有阿托伐他汀钙I型晶种。
-
公开(公告)号：US20080009540A1
公开(公告)日：2008-01-10
申请号：US11576396
申请日：2005-09-29
IPC分类号： A61K31/401 , A61P43/00
CPC分类号： A61K31/401 , C07D207/34
摘要： Amorphous atorvastatin calcium having an enhanced stability contains about 2 to about 8 percent by weight water. A process for preparing the amorphous atorvastatin calcium and a packaging system for maintaining the stability are described.
摘要翻译： 具有增强的稳定性的无定形阿托伐他汀钙含有约2至约8重量％的水。 描述了制备无定形阿托伐他汀钙的方法和用于保持稳定性的包装系统。
-
公开(公告)号：US20060004200A1
公开(公告)日：2006-01-05
申请号：US11157552
申请日：2005-06-21
IPC分类号： A61K31/513 , C07D45/02
CPC分类号： C07D319/06 , C07D239/42
摘要： Intermediate compounds for preparing rosuvastatin are prepared by a process comprising oxidizing hydroxy groups to aldehyde groups, using sodium hypochlorite and 2,2,6,6-tetramethyl piperidinyl oxy free radical (TEMPO) as a catalyst.
摘要翻译： 制备瑞舒伐他汀的中间体化合物是通过使用次氯酸钠和2,2,6,6-四甲基哌啶氧基自由基（TEMPO）作为催化剂将羟基氧化成醛基的方法制备的。
-
公开(公告)号：US20130211099A1
公开(公告)日：2013-08-15
申请号：US13703555
申请日：2011-06-16
申请人： Srinivas Katkam , Srinivas Polavarapu , Venkata Madhavi Yaddanapudi , Krishna Vinigari , Narasimha Rao Pagadala , Rajeshwar Reddy Sagyam
发明人： Srinivas Katkam , Srinivas Polavarapu , Venkata Madhavi Yaddanapudi , Krishna Vinigari , Narasimha Rao Pagadala , Rajeshwar Reddy Sagyam
IPC分类号： C07D491/04
CPC分类号： C07D491/04 , C07D491/044
摘要： Aspects of the present application relate to a microcrystalline monoclinic form of asenapine maleate represented by structural Formula (I); processes for its preparation; and pharmaceutically acceptable dosage forms thereof.
摘要翻译： 本申请的方面涉及由结构式（I）表示的微晶单斜晶形式的马来酸asenapine; 其准备过程; 及其药学上可接受的剂型。
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.032 秒)
